{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260624119051/en/TRYNGOLZA%C2%AE-olezarsen-approved-by-the-FDA-as-the-first-and-only-treatment-to-reduce-triglycerides-and-the-risk-of-acute-pancreatitis-in-patients-with-severe-hypertriglyceridemia-sHTG", "message": "News view counter 814721 successfully enlarged"}